Browse > Article
http://dx.doi.org/10.4014/mbl.1708.08002

Evaluation of Urease Inhibition Activity of Zerumbone in vitro  

Woo, Hyun Jun (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Lee, Min Ho (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Yang, Ji Yeong (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Kwon, Hye Jin (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Yeon, Min Ji (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Kim, Do Hyun (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Moon, Cheol (Department of Clinical Laboratory Science, Semyung University)
Park, Min (Department of Biomedical Laboratory Science, Daekyeung University)
Kim, Sa-Hyun (Department of Clinical Laboratory Science, Semyung University)
Kim, Jong-Bae (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Publication Information
Microbiology and Biotechnology Letters / v.45, no.3, 2017 , pp. 265-270 More about this Journal
Abstract
A key virulence factor for urinary tract pathogens is the enzyme urease, which catalyzes the hydrolysis of urea into ammonium ions and carbonic acid. Urease activity plays an important role in the pathogenesis of urinary tract infection. In this study, the inhibitory effect of zerumbone against six urease-producing bacteria (Klebsiella oxytoca, K. pneumoniae, Morganella morganii, Proteus mirabilis, P. vulgaris, and Staphylococcus saprophyticus) and their urease activities were evaluated. The results of the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests showed that zerumbone had antibacterial effect against these six urease-producing bacteria. The MIC and MBC of zerumbone ranged from 0.5 to 2 mM and 1 to 4 mM, respectively. In the urease inhibitory assay, zerumbone showed better urease inhibition ($56.28{\pm}2.45-37.83{\pm}3.47%$) than the standard urease inhibitor, acetohydroxamic acid ($40.46{\pm}1.94-22.99{\pm}3.53%$). However, zerumbone did not affect the levels of the urease subunit. These results clearly indicated that zerumbone has antibacterial potential against urease-producing bacteria and possesses excellent bacterial urease inhibition properties.
Keywords
Zerumbone; urease; anti-urease activity; urease inhibition; natural compound;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Rosenstein IJ, Hamilton-Miller JM, Brumfitt W. 1981. Role of urease in the formation of infection stones: comparison of ureases from different sources. Infect. Immun. 32: 32-37.
2 Amtul Z, Rahman AU, Siddiqui RA, Choudhary MI. 2002. Chemistry and mechanism of urease inhibition. Curr. Med. Chem. 9: 1323-1348.   DOI
3 CLSI. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. Clinical and Laboratory Standards Institute. M07-A9.
4 Yoo TH, Lee MH, Park M, Lee J, Woo HJ, Kim HW, et al. 2015. Detection of EBV-encoded small RNA from diffuse large B-cell lymphoma patients by RT-PCR method. Biomed Sci Lett. 21: 227-232.   DOI
5 Muhammad N, Saeed M, Khan A, Adhikari A, Wadood A, Khan KM, et al. 2014. A new urease inhibitor from Viola betonicifolia. Molecules 19: 16770-16778.   DOI
6 Bhat RG, Katy TA, Place FC. 2011. Pediatric urinary tract infections. Emerg Med. Clin. North Am. 29: 637-653.   DOI
7 Foxman B. 2014. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 28: 1-13.   DOI
8 Hooton TM. 2012. Clinical practice. Uncomplicated urinary tract infection. N. Engl. J. Med. 366: 1028-1037.   DOI
9 Nicolle LE. 2012. Urinary catheter-associated infections. Infect. Dis. Clin. North Am. 26: 13-27.   DOI
10 Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. 2015. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13: 269-284.   DOI
11 Nielubowicz GR, Mobley HL. 2010. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7: 430-441.   DOI
12 Raz R, Colodner R, Kunin CM. 2005. Who are you--Staphylococcus saprophyticus? Clin. Infect. Dis. 40: 896-898.   DOI
13 Williams JJ, Rodman JS, Peterson CM. 1984. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N. Engl. J. Med. 311: 760-764.   DOI
14 Kosikowska P, Berlicki L. 2011. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert. Opin. Ther. Pat. 21: 945-957.   DOI
15 Zhang L, Mulrooney SB, Leung AF, Zeng Y, Ko BB, Hausinger RP, et al. 2006. Inhibition of urease by bismuth(III): implications for the mechanism of action of bismuth drugs. Biometals 19: 503-511.   DOI
16 Griffith DP, Gibson JR, Clinton CW, Musher DM. 1978. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J. Urol. 119: 9-15.   DOI
17 Bailie NC, Osborne CA, Leininger JR, Fletcher TF, Johnston SD, Ogburn PN, et al. 1986. Teratogenic effect of acetohydroxamic acid in clinically normal beagles. Am. J. Vet. Res. 47: 2604-2611.
18 Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N. 1991. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur. Urol. 20: 243-247.   DOI
19 Griffith DP, Khonsari F, Skurnick JH, James KE. 1988. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. J. Urol. 140: 318-324.   DOI
20 Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, Yoshihiro A, et al. 2002. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha,beta-unsaturated carbonyl group is a prerequisite. Carcinogenesis 23: 795-802.   DOI
21 Wahab SIA, Abdul AB, Yeel HC, Alzubairi AS, Elhassan MM, Syam MM. 2008. Anti-Tumor activities of analogues derived from the bioactive compound of Zingiber zerumbet. Int. J. Cancer Res. 4: 154-159.   DOI
22 Ohnishi K, Irie K, Murakami A. 2009. In vitro covalent binding proteins of zerumbone, a chemopreventive food factor. Biosci Biotechnol. Biochem. 73: 1905-1907.   DOI
23 Sulaiman MR, Perimal EK, Akhtar MN, Mohamad AS, Khalid MH, Tasrip NA, et al. 2010. Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia 81: 855-858.   DOI
24 Prasannan R, Kalesh KA, Shanmugam MK, Nachiyappan A, Ramachandran L, Nguyen AH, et al. 2012. Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem Pharmacol. 84: 1268-1276.   DOI
25 Khan AW, Jan S, Parveen S, Khan RA, Saeed A, Tanveer AJ, et al. 2012. Phytochemical analysis and enzyme inhibition assay of Aerva javanica for Ulcer. Chem. Cent. J. 6: 76.
26 Tsuboi K, Matsuo Y, Shamoto T, Shibata T, Koide S, Morimoto M, et al. 2014. Zerumbone inhibits tumor angiogenesis via $NF-{\kappa}B$ in gastric cancer. Oncol Rep. 31: 57-64.   DOI
27 Rahman HS, Rasedee A, Yeap SK, Othman HH, Chartrand MS, Namvar F, et al. 2014. Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. Biomed Res Int. 2014: 920742.
28 Chen BY, Lin DP, Wu CY, Teng MC, Sun CY, Tsai YT, et al. 2011. Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of $NF-{\kappa}B$, iNOS, and $TNF-{\alpha}$ expression and reduction of MDA accumulation. Mol. Vis. 17: 854-863.
29 Nakamura Y, Yoshida C, Murakami A, Ohigashi H, Osawa T, andUchida K. 2004. Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes. FEBS Lett. 572: 245-250.   DOI
30 Jantan I, Raweh SM, Sirat HM, Jamil S, Mohd Yasin YH, Jalil J, et al. 2008. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine 15: 306-309.   DOI
31 Khan H, Khan MA, Hussan I. 2007. Enzyme inhibition activities of the extracts from rhizomes of Gloriosa superba Linn (Colchicaceae). J. Enzyme Inhib. Med. Chem. 22: 722-725.   DOI
32 Lateef M, Iqbal L, Fatima N, Siddiqui K, Afza N, Zia-ul-Haq M, et al. 2012. Evaluation of antioxidant and urease inhibition activities of roots of Glycyrrhiza glabra. Pak. J. Pharm. Sci. 25: 99-102.
33 Kuwahara H, Miyamoto Y, Akaike T, Kubota T, Sawa T, Okamoto S, et al. 2000. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect. Immun. 68: 4378-4383.   DOI